What is the approximate price of the imported version of Encorafenib?
Encorafenib (Encorafenib), as a targeted therapy drug targeting BRAF V600 mutations, is mainly used to treat cancers such as metastatic melanoma and colorectal cancer. At present, the drug has not been officially launched in mainland China, so if domestic patients need to use it, they can only purchase it through overseas channels. Since canafenib is an imported drug, its price has always been relatively high, especially for the original version, and the economic burden cannot be ignored.
The original drug of Canafenib currently sold overseas mainly comes from the European market, with two specifications: 75mg×42 tablets and 75mg×168 tablets. According to the market price, the price of 75mg×42 capsules may reach more than 10,000 yuan per box, and the price of 75mg×168 tablets per box is as high as 40,000 yuan. The price will be affected by exchange rate changes and supply channels, and the final cost will be determined at the time of purchase. This high drug price is undoubtedly a great pressure for ordinary patient families.

It is worth noting that in order to ease the financial burden on patients, some patients choose to use overseas versions of generic drugs. At present, the generic drug of Canafenib produced in Laos is already on the market, and its drug ingredients are basically the same as the original drug. The price of this version is relatively affordable, with a box of 75mg×168 tablets priced at about 4,000 yuan. This provides patients with a more feasible alternative, especially suitable for long-term users who need to control the cost of treatment.
However, when patients choose to purchase canafenib, whether it is the original research or a generic version, they should do so through formal channels to ensure drug quality and medication safety. At the same time, it is recommended to use the drug under the guidance of a doctor, and regularly evaluate the efficacy and side effects according to the progress of the disease. Do not adjust the dosage or stop the drug without authorization, so as not to affect the treatment effect.
Reference materials:https://www.braftovi.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)